International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
Thomas Günther(Université Toulouse III - Paul Sabatier), Stefan Schulz(Otto-von-Guericke University Magdeburg), Giovanni Tulipano(Brescia University), Amelie Lupp(Friedrich Schiller University Jena), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Hans‐Jürgen Kreienkamp(Universität Hamburg), Шломо Мелмед(Salk Institute for Biological Studies), Corinne Bousquet(Centre National de la Recherche Scientifique), Pascal Dournaud(Délégation Paris 7), Zsolt Csaba(Inserm), Márta Korbonits(Queen Mary University of London), Hans‐Jürgen Wester(Theranostics (New Zealand)), Michael D. Culler(Ipsen (United States))
Cited by 251
Related Papers
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
|The Lancet|2001|643
<sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
|Journal of Nuclear Medicine|2015|526
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390